Results 21 to 30 of about 2,671,914 (293)

Inflammatory bowel disease-specific autoantibodies in HLA-B27-associated spondyloarthropathies: Increased prevalence of ASCA and pANCA [PDF]

, 2004
Aims: An association between inflammatory bowel disease (IBD) and spondyloarthropathies (SpA) has repeatedly been reported. The aim of the present study was to investigate whether serologic markers of IBD, e. g.
Folwaczny, Christian, Kellner, H., J. Glas, Marker-Hermann, E., R. Gruber, Brumberger, V., V. Brumberger, Glas, J., Gruber, R., H. Kellner, C. Folwaczny, Török, H.-P., E. Märker-Hermann, C. Strasser, Strasser, C., H.-P. Török   +15 more
core   +1 more source

Evaluation of the level of alloantibodies and selected cytokines in kidney recipients

Journal of Pre-Clinical and Clinical Research, 2022
Introduction and objective Anti-HLA antibodies, especially anti-DSA, are believed to be potentially involved in acute and chronic rejection. New techniques, e.g. flow fluorimetry, can be an excellent supplement to the lymphocytotoxic tests currently used
Iwona Wojciechowska-Koszko, Monika Nowosiad-Magda, Barbara Krasnodębska-Szponder, Paulina Roszkowska, Michał Sławiński, Paweł Kwiatkowski   +5 more
doaj   +1 more source

C1q-binding anti-HLA antibody assay: A test dilemma

Saudi Journal of Kidney Diseases and Transplantation, 2016
Detection of donor-specific anti-HLA antibodies in patients with kidney graft, or awaiting kidney graft, acts as a predictor for antibody mediated rejection.
Ali H Hajeer
doaj   +1 more source

Anti-phospholipid-antibodies in patients with relapsing polychondritis [PDF]

, 1998
Relapsing polychondritis (RP) is an extremly rare multisystemic disease thought to be of autoimmune origin. In order to assess if RP is associated with anti-phospholipid antibodies (aPL), clinical data and sera of 21 patients with RP were collected in a ...
Schlosser, U., Schmitz, G., Lang, B., Zeuner, M., Straub, R. H., Rauh, G., Schòlmerich, J.   +6 more
core   +1 more source

Novel method for simultaneously detecting HPA and HLA antibodies using Luminex microbeads

Journal of Translational Medicine, 2019
Background Alloantibodies against human platelet antigens (HPAs) and human leukocyte antigen (HLA) are implicated in several immune-mediated platelet disorders.
Sudan Tao, Shu Chen, Xiaozhen Hong, Ji He, Faming Zhu   +4 more
doaj   +1 more source

Significance of HLA-matching and anti-HLA antibodies in heart transplant patients receiving induction therapy?

, 2022
OBJECTIVES: Though Human Leukocyte Antigen (HLA) matching benefits are demonstrated in renal transplantation, evidence in heart transplantation is lacking, and its clinical feasibility is uncertain.
Poncelet, Alain, Van Caenegem, Olivier, Latinne, Dominique, Gavroy, Benjamin, Timmermans, Thierry, Jacquet, Luc-Marie, Mastrobuoni, Stefano   +6 more
core   +1 more source

COMPARISON OF DIFFERENT METHODS OF ANTI-HLA ANTIBODIES DETECTION IN DIAGNOSIS OF ANTIBODY-MEDIATED RENAL ALLOGRAFT REJECTION

Вестник трансплантологии и искусственных органов, 2016
Aim: to analyze the relationship between circulating anti-HLA antibodies (class-I and class-II), renal pathology and C4d deposition in cases of late acute and chronic antibody-mediated renal allograft rejection according to the method of antibodies ...
E. S. Ivanova, E. S. Stolyarevich, O. E. Gichkun, N. B. Bogdanova, F. S. Baranova, L. Yu. Artyukhina, N. A. Tomilina   +6 more
doaj   +1 more source

Killer cell immunoglobulin-like receptors and their ligands : assessment of potential diagnostic and immunotherapeutic value [PDF]

, 2014
Human natural killer (NK) cells constitute an important arm of the innate immune system, which participates in protection against viral infections and elimination of malignant diseases.
Czaja, Karol Gustaw
core   +1 more source

SARS-CoV-2 mRNA vaccination is not associated with the induction of anti-HLA or non-HLA antibodies

, 2022
BACKGROUND: SARS-CoV-2 vaccination is strongly recommended in kidney transplant recipients (KTR) and dialysis patients. Whether these vaccinations may trigger alloantibodies, is still debated. METHODS: In the current study we evaluated the effect of SARS-
Claas, Frans H. J., Wijtvliet, Veerle P.W.M., Verheyden, Sonja, Massart, Annick, Depreter, Barbara, Heylen, Christine, Coeman, Elke, Abrams, Steven, De Winter, Benedicte Y., Wijtvliet, Veerle P. W. M., Ariën, Kevin K., Pipeleers, Lissa, Ledeganck, Kristien J., Hellemans , Rachel, Abramowicz, Daniel, Wissing, Karl Martin, Claas, Frans H.J., Hellemans, Rachel, Veerle P W M Wijtvliet, Ari\uebn, Kevin K., Frans H.J. Claas, Daniel Abramowicz, Kristien J. Ledeganck, Rachel Hellemans, Veerle P.W.M. Wijtvliet, Sonja Verheyden, Steven Abrams, Annick Massart, Lissa Pipeleers, Kevin K. Ariën, Barbara Depreter, Elke Coeman, Christine Heylen, Benedicte Y. De Winter, Karl Martin Wissing   +34 more
core   +1 more source

Ramifications of the HLA-I Allelic Reactivity of Anti-HLA-E*01:01 and Anti-HLA-E*01:03 Heavy Chain Monoclonal Antibodies in Comparison with Anti-HLA-I IgG Reactivity in Non-Alloimmunized Males, Melanoma-Vaccine Recipients, and End-Stage Renal Disease Patients

Antibodies, 2022
Serum anti-HLA-I IgG are present in non-alloimmunized males, cancer patients, and transplant recipients. Anti-HLA-I antibodies are also present in intravenous immunoglobulin (IVIg), prepared from the plasma of thousands of healthy donors.
Mepur H. Ravindranath, Narendranath M. Ravindranath, Fatiha El Hilali, Senthamil R. Selvan, Edward J. Filippone   +4 more
doaj   +1 more source